News

Fluidra, the global leader in equipment and connected solutions in the pool and wellness sector, closed 2021 with its best results ever. The company ended the year with sales of 2,187 million

Elliptic Labs (EuroNext Growth: ELABS.OL), a global AI software company and the world leader in AI Virtual Smart Sensors™, announced that its AI Virtual Presence Sensor will be making its laptop

Regulatory News:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220227005069/en/

Vifor Fresenius Medical Care Renal Pharma (VFMCRP)

Osmium Partners today issued a letter to the Redbubble Board of Directors.

Letter #1’s full text is available at www.unlockshareholdervalue.com.

Dear Redbubble Board Members,

Osmium Partners

KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) today announced that Matt Salem, Chief Executive Officer, will present at the Citi 2022 Global Property CEO Conference on Monday, March 7

State Street Corporation (NYSE: STT) announced today that its Chief Financial Officer, Eric Aboaf, will participate virtually in RBC Capital Markets’ Global Financial Institutions Conference on

In an order entered on February 24, 2022, the Public Service Commission of West Virginia (PSC) approved a request to establish new water and wastewater rates for West Virginia American Water

State Street Global Advisors, the asset management business of State Street Corporation (NYSE: STT), today announced several changes to its SPDR^® MSCI ACWI Low Carbon Target ETF (LOWC).

Effective

Ozon Holdings PLC (NASDAQ and MOEX: “OZON”, thereafter referred to as “Ozon” or the “Company”), a leading Russian e-commerce platform, announces that on February 24, 2022 its banking subsidiary

The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.21 per share on the Company’s Class A and Class B Common Stock, payable April 7, 2022, to

Zendesk, Inc. (NYSE: ZEN) today announced that it has terminated the Agreement and Plan of Merger by and among Zendesk, Milky Way Acquisition Corp., and Momentive Global Inc. (NASDAQ: MNTV), after

Nutrien Ltd. (TSX and NYSE: NTR) announced today that its 2021 Annual Report, including Management’s Discussion and Analysis and Audited Consolidated Financial Statements, as well as its Annual

Altria Group, Inc. (Altria) (NYSE: MO) today announced that its Board of Directors declared a regular quarterly dividend of $0.90 per share, payable on April 29, 2022 to shareholders of record as

REV Group (NYSE: REVG) today announced that it is planning to release its first quarter fiscal 2022 results before market open on Wednesday, March 9, 2022. The results will be discussed during a

Chatham Asset Management, LLC (“Chatham”), a leading private investment firm, and R.R. Donnelley & Sons Company (“RRD” or the “Company”) today announced that they have completed a transaction in

Regulatory News:

Philip Morris International Inc. (NYSE: PM) announces the temporary suspension of its operations in Ukraine, including at its factory in Kharkiv.

“The safety and security of

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced

LiveRamp® (NYSE: RAMP), the leading global data connectivity platform, today announced that LiveRamp CEO Scott Howe will present at the BMO Digital Advertising Summit on Thursday, March 3rd at 9:00

Pitney Bowes Inc. (NYSE:PBI), a global shipping and mailing company that provides technology, logistics, and financial services, today announced its call for redemption of all of its outstanding

Tokens.com Corp. (NEO Exchange Canada: COIN) (Frankfurt Stock Exchange: 76M) (OTCQB US: SMURF) (“Tokens.com” or “the Company”), a publicly-traded company that invests in Web3 crypto assets and

ExxonMobil has made a final investment decision to expand carbon capture and storage at its LaBarge, Wyoming, facility, which has captured more CO₂ than any other facility in the world to date. The

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced a Trial-in-Progress poster detailing the Phase 1 portion of the LuMIERE clinical study for its targeted radiotherapy candidate FAP-2286 and a